Consensus Humana Inc.

Equities

HUM

US4448591028

Managed Healthcare

Market Closed - Nyse Other stock markets 02:30:02 10/12/2025 am IST			5-day change	1st Jan Change
250.39 ^USD	-2.34%		+3.48%	-1.31%

06/12	Sector Update: Health Care Stocks Lower Late Afternoon	MT
06/12	Sector Update: Health Care	MT

Evolution of the Average Target: Humana Inc.

Evolution of the Target Price: Humana Inc.

Changes in Analyst Recommendations: Humana Inc.

d3e.YnQ0zGtOYEEOLukVNxWCDfghYI5_sXGJ0atpy5k7EQk.NkNOpF8nVBJ6Y51CZli6RMlGLtcmxgP8s50-gfVSRDEgFVz7CD4GDj12jg~f812710eedd4f55dd1be91eba16b88ff

Analysts' recommendations: Humana Inc.

06/12	Sector Update: Health Care	MT
06/12	Humana Shares Rise After Upgrade From Jefferies	MT
05/12	Analyst recommendations: Humana, Newmont, Robert Half, Apple, Macy's…
05/12	Jefferies Upgrades Humana to Buy From Hold, Adjusts Price Target to $313 From $253	MT
24/11	Barclays Adjusts Price Target on Humana to $234 From $245, Maintains Equalweight Rating	MT
24/11	Goldman Sachs Adjusts Price Target on Humana to $215 From $235, Maintains Sell Rating	MT
20/11	Wolfe Research Adjusts Price Target on Humana to $300 From $313, Maintains Outperform Rating	MT
10/11	Truist Securities Adjusts Humana Price Target to $285 From $300, Maintains Hold Rating	MT
07/11	Deutsche Bank Adjusts Humana Price Target to $231 From $250, Maintains Buy Rating	MT
06/11	Jefferies Adjusts Price Target on Humana to $253 From $256, Maintains Hold Rating	MT
06/11	Piper Sandler Adjusts Price Target on Humana to $265 From $272, Maintains Neutral Rating	MT
06/11	Leerink Partners Adjusts Price Target on Humana to $267 From $273, Maintains Market Perform Rating	MT
06/11	Guggenheim Adjusts Price Target on Humana to $312 From $326, Maintains Buy Rating	MT
05/11	Evercore ISI Adjusts Price Target on Humana to $285 From $295	MT
05/11	(HUM) Humana Expects 2025 Adjusted EPS About $17, vs. FactSet Est of $17.07	MT
10/10	CVS, UnitedHealth Score High in 2026 Quality Ratings	MT
09/10	Mizuho Adjusts Price Target on Humana to $345 From $300, Maintains Outperform Rating	MT
07/10	Wells Fargo Adjusts Humana Price Target to $347 From $344	MT
06/10	Wolfe Research Adjusts Price Target on Humana to $313 From $283, Maintains Outperform Rating	MT
02/10	Humana Shares Rise on 2026 Medicare Advantage Star Rating Information	DJ
02/10	Humana says it has 1.2 million members in 4-star & above plans for 2026	RE
02/10	Barclays Adjusts Price Target on Humana to $245 From $315, Maintains Equalweight Rating	MT
05/09	Bernstein Adjusts Price Target on Humana to $341 From $269, Maintains Outperform Rating	MT
05/09	Analyst recommendations: Alphabet, Broadcom, Lululemon, Lucid Group, Nvidia…
04/09	Barclays Adjusts Humana Price Target to $315 From $275	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	HUMANA INC.					+12.77%
	UNITEDHEALTH GROUP INC.					+20.05%
	ELEVANCE HEALTH, INC.					+17.1%
	CIGNA					+24.74%
	CENTENE CORPORATION					+5.44%
	MOLINA HEALTHCARE, INC.					+14.98%
	ALIGNMENT HEALTHCARE, INC.					+9.55%
	PROGYNY, INC.					+17.81%
	CLOVER HEALTH INVESTMENTS, CORP.					+26.3%
	MEDI ASSIST HEALTHCARE SERVICES LIMITED					+35.42%
	Average					+18.42%
	Weighted average by Cap.					+19.15%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

250.39USD

Average target price

289.12USD

Spread / Average Target

+15.47%

High Price Target

353.00USD

Spread / Highest target

+40.98%

Low Price Target

215.00USD

Spread / Lowest Target

-14.13%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Jefferies & Co.
Barclays
Goldman Sachs
Wolfe Research
Truist Securities
Deutsche Bank Securities
Guggenheim
Leerink Partners
Piper Sandler
Evercore ISI
Mizuho Securities
Wells Fargo Securities
Bernstein
BofA Securities
RBC Capital Markets
Baird
JPMorgan Chase
Morgan Stanley
TD Cowen
Raymond James
Oppenheimer
UBS
Nephron Research
Cantor Fitzgerald
Stephens Inc.
KeyBanc Capital Markets
Zacks Investment Research
Argus
SVB Securities LLC
Cowen
Credit Suisse
Loop Capital
BMO Capital
SVB Leerink
Citigroup
Seaport Global Securities